Nantahala Capital Management - LAVA THERAPEUTICS NV ownership

LAVA THERAPEUTICS NV's ticker is LVTX and the CUSIP is N51517105. A total of 20 filers reported holding LAVA THERAPEUTICS NV in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of LAVA THERAPEUTICS NV
ValueSharesWeighting
Q2 2022$953,000
-35.2%
322,980
-3.3%
0.05%
-26.2%
Q1 2022$1,470,000
-25.9%
334,164
-7.4%
0.06%
-7.1%
Q4 2021$1,984,000
-9.2%
360,808
-2.3%
0.07%
+1.4%
Q3 2021$2,186,000
-47.3%
369,290
-3.1%
0.07%
-41.5%
Q2 2021$4,148,000
-28.4%
381,2270.0%0.12%
-30.2%
Q1 2021$5,791,000381,2270.17%
Other shareholders
LAVA THERAPEUTICS NV shareholders Q3 2021
NameSharesValueWeighting ↓
Bruce & Co., Inc. 771,874$1,150,0920.39%
Novo Holdings A/S 2,400,000$3,528,0000.26%
Redmile Group, LLC 2,074,372$3,090,8140.15%
Alpha Wave Global, LP 109,097$162,5550.10%
Artal Group S.A. 200,000$2940.01%
Tower Research Capital LLC (TRC) 11,960$17,5810.00%
OSAIC HOLDINGS, INC. 48$710.00%
PNC FINANCIAL SERVICES GROUP, INC. 65,000$95,5500.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 100$1490.00%
View complete list of LAVA THERAPEUTICS NV shareholders